Christine Danforth
Family Medicine · Atlanta, GANPI 1679665558
Payments from drug & device makers
Across 359 payments — averaging $14.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$930
- Lilly USA, LLC$764
- Novo Nordisk$671
- AstraZeneca$610
- Amgen$420
- Sanofi-aventis U.S. LLC$244
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,25898%
- Education$1142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 61 | $930 |
| Lilly USA, LLC | 66 | $764 |
| Novo Nordisk | 58 | $671 |
| AstraZeneca | 33 | $610 |
| Amgen | 28 | $420 |
| Sanofi-aventis U.S. LLC | 16 | $244 |
| GSK | 11 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $183 |
| Boehringer Ingelheim | 9 | $154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $131 |
| Mylan Specialty L.p. | 6 | $111 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $99 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $97 |
| Bayer | 4 | $96 |
| Arbor Pharmaceuticals, Inc. | 6 | $87 |
| Supernus Pharmaceuticals, Inc. | 3 | $72 |
| Dexcom, Inc. | 3 | $58 |
| Eisai Inc. | 3 | $49 |
| Astellas Pharma US Inc | 2 | $49 |
| Pfizer | 3 | $47 |
| Esperion Therapeutics, Inc. | 3 | $40 |
| Genentech USA, Inc. | 2 | $32 |
| Abbott | 2 | $30 |
| Avanir Pharmaceuticals, Inc. | 2 | $30 |
| Sunovion Pharmaceuticals Inc. | 2 | $29 |
| Shield Therapeutics Inc | 1 | $23 |
| Biotronik NRO, Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
| Johnson & Johnson | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$148
How this compares
$5,372 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 98 | $144,742 |
| EliquisApixaban | 36 | $48,754 |
| JardianceEmpagliflozin | 30 | $41,231 |
| TrulicityDulaglutide | 22 | $32,381 |
| FarxigaDapagliflozin Propanediol | 17 | $27,070 |
| MounjaroTirzepatide | 12 | $20,612 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 169 | $17,957 |
| JanuviaSitagliptin Phosphate | 16 | $16,818 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $13,415 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 379 | $12,830 |
| SymbicortBudesonide/Formoterol Fumarate | 18 | $9,125 |
| Novolog FlexpenInsulin Aspart | 12 | $6,115 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $5,541 |
| Diclofenac Sodium | 183 | $4,763 |
| Fluticasone Propionate | 268 | $2,460 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $671 | $144,74298 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $764 | $52,99334 claims |
| PfizerEliquis | $47 | $48,75436 claims |
| Boehringer IngelheimJardiance | $154 | $41,23130 claims |
| AstraZenecaFarxiga, Symbicort | $610 | $36,19535 claims |
| GSKTrelegy Ellipta | $185 | $13,41517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Atlanta
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Nadia CameronAtlanta$2.1M
- Otis PowellAtlanta$608K
- Thinh NguyenAtlanta$427K
- Patricia MarshAtlanta$175K
- Contessa MetcalfeAtlanta$157K
- Michelle EvansAtlanta$127K
- Mark TannerAtlanta$94K
- Ambar KulshreshthaAtlanta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.